Mounjaro Articles - Page 80

Concerned About Holiday Weight Gain? Prestige Men's Health Offers Affordable, Medically-Supervised Semaglutide Options for Qualifying Individuals

As the holiday season approaches, many individuals express concerns regarding potential weight gain. Prestige Men's Health in Holladay is offering medically supervised weight-loss programs using GLP-1 treatments like semaglutide, providing screening, labs, and continuous monitoring. This comes as more Utah residents seek medical guidance for weight management during this time.

Shotlee·Dec 11, 2025·4 min read

Pharmaceuticals

Cipla Introduces Tirzepatide Drug Yurpeak for Diabetes and Obesity Treatment in India

Cipla has released Yurpeak (tirzepatide), a weekly injectable medication designed for adults managing obesity and type 2 diabetes. As the second tirzepatide brand from Lilly available in India, Yurpeak will be accessible through prescription in a user-friendly KwikPen.

Shotlee·Dec 10, 2025·3 min read

Health

ITV's Lorraine Star Reveals 4-Stone Weight Loss Journey with Mounjaro

An ITV presenter, known for her financial expertise on Lorraine, has publicly discussed her weight loss journey. She attributes her four-stone weight loss to the use of Mounjaro, resulting in a significant change in her dress size.

Shotlee·Dec 10, 2025·1 min read

Health

Mounjaro by Eli Lilly Approved for China's State Insurance Coverage for Diabetes

Mounjaro, a drug by Eli Lilly, is set to be included in China's state-run health insurance program for individuals with type 2 diabetes starting January 1. This inclusion aims to improve access to the medication, although increased sales may be balanced by reduced prices. The drug was introduced in China earlier this year.

Shotlee·Dec 8, 2025·2 min read

Health

WHO Issues New Advice on GLP-1 Weight Loss Medications: Key Points

The World Health Organization (WHO) has provided new guidance on using GLP-1 drugs like Ozempic and Wegovy for obesity. The recommendations include considerations for adults and highlight the importance of lifestyle changes alongside medication.

Shotlee·Dec 7, 2025·2 min read

Health

Ozempic, a Diabetes Medication, Slated for India Launch This Month

Novo Nordisk is set to introduce Ozempic in India, complementing their existing semaglutide product line. This launch occurs amidst strong competition from Eli Lilly's Mounjaro. The new medication may also be prescribed for other health conditions.

Shotlee·Dec 4, 2025·1 min read

Health

Research Indicates Weight-Loss Medication Mounjaro Not Worth the Cost

New research suggests that the weight-loss medication Mounjaro may not be a worthwhile investment at its present cost. The study highlights concerns about the drug's value in relation to its price. Cost-effectiveness is questioned.

Shotlee·Dec 4, 2025·1 min read

Health

Eli Lilly Reduces Zepbound Prices Amidst Weight Loss Medication Competition

Eli Lilly has announced price cuts for its weight loss medication Zepbound, aiming to improve accessibility for patients. The company is also seeking to increase the use of its digital healthcare platform, LillyDirect, through these changes.

Shotlee·Dec 1, 2025·3 min read

Health

WHO Issues Guidance on GLP-1 Medications for Obesity, Hailing Them as a "Scientific Advance" and "New Era"

The World Health Organization (WHO) has issued new guidelines advocating for the use of GLP-1 drugs in the treatment of obesity. These guidelines suggest that GLP-1 therapies can be used long-term by adults, excluding pregnant women, when combined with intensive behavioral therapy.

Shotlee·Dec 1, 2025·3 min read

Mounjaro

Latest Articles

Concerned About Holiday Weight Gain? Prestige Men's Health Offers Affordable, Medically-Supervised Semaglutide Options for Qualifying Individuals

Cipla Introduces Tirzepatide Drug Yurpeak for Diabetes and Obesity Treatment in India

ITV's Lorraine Star Reveals 4-Stone Weight Loss Journey with Mounjaro

Mounjaro by Eli Lilly Approved for China's State Insurance Coverage for Diabetes

WHO Issues New Advice on GLP-1 Weight Loss Medications: Key Points

Ozempic, a Diabetes Medication, Slated for India Launch This Month

Research Indicates Weight-Loss Medication Mounjaro Not Worth the Cost

Eli Lilly Reduces Zepbound Prices Amidst Weight Loss Medication Competition

WHO Issues Guidance on GLP-1 Medications for Obesity, Hailing Them as a "Scientific Advance" and "New Era"

Mysterious Flat Affect Symptom in GLP-1 Users

Ozempic, Mounjaro & More: Yale Study Exposes Risky Online GLP-1 Prescribing

GLP-1 Drugs Linked to Skin Pain: New Reports of Dysesthesia & Allodynia

Beyond Healthspan: The New Midlife Goal for Men

Doctor Issues Warning About Overlooked Mounjaro Side Effect